Early Detection of Dementia with Smart Devices
Early Detection of Dementia with Smart Devices
Digital biomarkers of cognitive decline could alert us to the early stages of dementia before irreversible damage occurs.
Early Detection of Dementia with Smart Devices
Early Detection of Dementia with Smart Devices

Digital biomarkers of cognitive decline could alert us to the early stages of dementia before irreversible damage occurs.

Digital biomarkers of cognitive decline could alert us to the early stages of dementia before irreversible damage occurs.

pharma & biotech
Remdesivir Shows Promise in Largest of Several Clinical Trials
Remdesivir Shows Promise in Largest of Several Clinical Trials
Catherine Offord | Apr 30, 2020
Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.
Enter Our Annual Top 10 Innovations Contest
Enter Our Annual Top 10 Innovations Contest
The Scientist Staff | Apr 28, 2020
Submit your new product now to have a chance at being selected for a coveted spot in The Scientist’s 2020 competition.
Consortium Identifies Risks of Viral Contamination in Biopharma
Consortium Identifies Risks of Viral Contamination in Biopharma
Emma Yasinski | Apr 27, 2020
Nine of the 20 pharma companies that participated in a study had experienced at least one viral contamination event between 1985 and 2018.
Natural Killer Cell Therapies Catch Up to CAR T
Natural Killer Cell Therapies Catch Up to CAR T
Bianca Nogrady | Apr 1, 2020
There’s a new cell-based cancer immunotherapy on the block.
FDA Gives Abbott Emergency Use of Five-Minute Coronavirus Test
FDA Gives Abbott Emergency Use of Five-Minute Coronavirus Test
Kerry Grens | Mar 30, 2020
The machine can be run in doctor’s offices and other point-of-care settings to give rapid results.
Opinion: Stop Private Speculation in COVID-19 Research
Opinion: Stop Private Speculation in COVID-19 Research
Emiliano Brancaccio, Ugo Pagano | Mar 23, 2020
We present an economic plan for a collective sharing of scientific knowledge on the pandemic.
UK Government to Boost R&D Spending
UK Government to Boost R&D Spending
Catherine Offord | Mar 13, 2020
The 2020 budget includes a 15 percent increase in public funding for research and development next year, but some scientists want more details on where the money will go.
Variation in Cannabis Testing Challenges a Young Industry
Variation in Cannabis Testing Challenges a Young Industry
Katarina Zimmer | Mar 1, 2020
The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.
How Aripiprazole’s Promise for Treating Autism Fell Short
How Aripiprazole’s Promise for Treating Autism Fell Short
Hannah Furfaro | Feb 27, 2020
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.